Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher Latoz
Institution:
Hollister (United States)
Observed institution:
Hollister (United States)
ORCID:
0000-0003-2813-4150
Observed ORCID:
0000-0003-2813-4150
OpenAlex ID:
A5035674898
Stability considerations for drug-device combination products-21 CFR part 4 update
2023
·
Christopher Latoz
, Laure Larkin
, et al.
·
AAPS Open
·
14
PDF
Meeting Report: Vaccine Stability Considerations to Enable Rapid Development and Deployment
2021
·
Mark Alasandro
, Dilip Choudhury
, et al.
·
AAPS Open
·
8
PDF
Kinetics and mechanisms of drug degradation
2024
·
Christopher M. Riley
, Laura Pack
, et al.
·
Elsevier eBooks
·
2
Stability studies: General regulatory considerations and regional differences
2024
·
Kim Huynh-Ba
, Christopher Latoz
, et al.
·
Elsevier eBooks
·
2
Systematic approaches to determining the disposition of temperature-compromised drug products: a regulatory and stability science–based review
2026
·
Christopher Latoz
, Kim Huynh-Ba
, et al.
·
AAPS Open
·
1
PDF
Contributors
2024
·
Andreas Abend
, Sharad Agarwal
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
6
Citation count:
27
H-index:
2
I10-index:
1
Year
Topic
Type
